Suven Pharmaceuticals Limited (SUVENPHAR) — Capital Reinvestment Ratio
Suven Pharmaceuticals Limited (SUVENPHAR) has a Capital Reinvestment Ratio of 0.24x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.04 Billion) in capital expenditures (Rs248.54 Million). Check SUVENPHAR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suven Pharmaceuticals Limited Capital Reinvestment Ratio (2019–2025)
This chart tracks Suven Pharmaceuticals Limited's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited cash flow conversion.
Annual Capital Reinvestment Ratio for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year Capital Reinvestment Ratio for Suven Pharmaceuticals Limited from 2019 to 2025. See how much free cash does Suven Pharmaceuticals Limited generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | Rs2.88 Billion | Rs1.56 Billion | ▲ +274.1% |
| 2024 | 0.14x | Rs3.58 Billion | Rs517.87 Million | ▼ -77.2% |
| 2023 | 0.63x | Rs4.51 Billion | Rs2.86 Billion | ▲ +178.2% |
| 2022 | 0.23x | Rs3.30 Billion | Rs751.87 Million | ▼ -21.2% |
| 2021 | 0.29x | Rs3.83 Billion | Rs1.11 Billion | ▲ +21.0% |
| 2020 | 0.24x | Rs4.16 Billion | Rs994.15 Million | ▼ -78.8% |
| 2019 | 1.13x | Rs504.05 Million | Rs567.86 Million | — |